Out of stock

This item is currently unavailable

Springer Community-Acquired Pneumonia

Name: Community-Acquired Pneumonia
Brand: Springer

Infectious & Contagious Diseases

Gone for 41 days. Could come back at any time — we're watching for you.

Out of stock 41 days · last price £180 · longest previous gap was 15 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 50 days · 50 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 50 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £144 (26 days, 52.0%)

Price range: £144 - £180

Price levels: 4 different prices over 50 days

Description

Pneumonia (along with influenza) is the sixth leading cause of death in adults. About 4 million adults develop pneumonia each year in the US, resulting in 64 million days of restricted activity, 39 million days of bed confinement, and 10 million days of lost work. Yet the admission rates to hospital, length of stay, investigations, antimicrobial therapy and prevention strategies vary greatly from one geographic area to the next, and the scientific basis for many of our management strategies for pneumonia is weak to nonexistent. There are over 100 microbial agents that can cause pneumonia and many of these, especially Streptococcus pneumoniae, Group A streptococcus, and Staphylococcus aureus, are in a state of flux in terms of changing antimicrobial resistance. This book is designed to provide new information about pneumonia and identify critical research questions that will come to the fore as we enter the 21st century.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1475782489
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Infectious & Contagious Diseases
Domain: Amazon UK
Release Date: 01 May 2013
Listed Since: 06 August 2014

Barcode

No barcode data available

Springer Community-Acquired Pneumonia

Gone for 41 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Pulmonary Infection: 857 (Advances in Experimental Medicine and Biology, 857)

Pulmonary Infection and Inflammation: 935 (Advances in Experimental Medicine and Biology, 935)

New and Evolving Infections of the 21st Century (Emerging Infectious Diseases of the 21st Century)

Legionella Pneumophila: Pathogenesis and Immunity (Infectious Agents and Pathogenesis)

Infections in the Adult Intensive Care Unit

Infections in the Adult Intensive Care Unit

Ventilator-Associated Pneumonia: 4 (Perspectives on Critical Care Infectious Diseases, 4)

Pulmonary Health and Disorders: 1150 (Advances in Experimental Medicine and Biology, 1150)

Serodiagnosis of the Infectious Diseases: Mycoplasma pneumoniae

Antimicrobial Resistance: A Crisis in Health Care: 390 (Advances in Experimental Medicine and Biology, 390)

Legionella: Methods and Protocols: 954 (Methods in Molecular Biology, 954)

Essential Infectious Disease Topics for Primary Care (Current Clinical Practice)

Tuberculosis: 215 (Current Topics in Microbiology and Immunology, 215)

The Pathogenic Spirochetes: strategies for evasion of host immunity and persistence

Infection Control in the ICU Environment: 5 (Perspectives on Critical Care Infectious Diseases, 5)

Preventing Legionellosis

Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance

Influenza and Respiratory Care: 968 (Advances in Experimental Medicine and Biology, 968)

Polymyxin Antibiotics: From Laboratory Bench to Bedside: 1145 (Advances in Experimental Medicine and Biology, 1145)

Noninvasive Ventilation in High-Risk Infections and Mass Casualty Events

Infection Prevention: New Perspectives and Controversies

Clinical Management of Pulmonary Disorders and Diseases: 1022 (Advances in Experimental Medicine and Biology, 1022)

Antimicrobials: New and Old Molecules in the Fight Against Multi-resistant Bacteria

Pathology of Septic Shock: 216 (Current Topics in Microbiology and Immunology, 216)